The fund’s research grants, totaling hundreds of thousands of dollars, will support research in life sciences, medical aspects of nanotechnology and the development of medical devices.

By participating in the new fund, the Johnson & Johnson Corporate Office of Science & Technology will be exposed to emergent scientific research, and be able to follow new scientific trends as they develop in real time. “We welcome the cooperation with Johnson & Johnson,” says Dr. Isaac Shariv, CEO of Yeda. “We believe this joint fund will lead to stronger ties between the company and Israel, to the mutual benefit of all sides.”

Yeda’s Chief Business Officer, Dr. Einat Zisman, says: “Since the announcement of the program, we have received a number of requests for support for exciting, original, multidisciplinary research projects. No doubt the existence of a joint fund with Johnson & Johnson will encourage the growth of novel directions in research at the Weizmann Institute and the development of new intellectual property.”

The Weizmann Institute of Science in Rehovot, Israel, is home to 2,500 scientists, students, technicians and supporting staff. Institute research efforts include the search for new ways of fighting disease and hunger, examining leading questions in mathematics and computer science, probing the physics of matter and the universe, creating novel materials and developing new strategies for protecting the environment.